Michael Macdonnell has been named as chief operating officer of biotechnology company Sensyne Health.
Macdonnell was previously director of global deployment at Google Health and is a former director of strategy at NHS England.
He will take up the newly created role later this month.
Sensyne Health uses artificial intelligence algorithms to analyse anonymised patient data to help pharmaceutical companies accelerate the development of new medicines.
Related Posts
-
October 31, 2018
June Felix named first female CEO of trading platform IG; Sensyne's chairman quits over potential for conflict with government role; and Pendragon appoints new CFO.
-
November 22, 2019
Former Shazam CEO Andrew Fisher joins online property portal as non-executive chair.
-
December 22, 2020
Direct Line Insurance Group has announced changes to its board and membership of its remuneration, investment and corporate responsibility committees. Adrian Joseph will join the board and become a member of the corporate responsibility committee from 1 January 2021. Joseph is managing director, Group AI and Data Solutions at BT. He was previously a senior partner at EY, head of the UK Data and Analytics practice for financial services, and a member of the European Innovation Board. Jane Hanson, independent non-executive director and chair of the board risk committee, will step down from the board in May after having served as a NED for over nine years. Senior independent director Richard Ward will become a member of the remuneration committee from 1 January 2021, and Fiona McBain, independent non-executive director, will become a member of the investment committee from the same date.
-
December 23, 2020
BHP senior independent director Kilsby is leaving to take on the role of board chair at Fortune Brands Home & Security.